PreprintAll rights reservedbioRxiv6 Oct 2026

Adenosylhomocysteinase drives epigenetic and metabolic reprogramming in ZFTA-RELA ependymoma

N. Yadav
O. Pelcher
R. G. R. Mooli
R. B. Cameron
A. Delaidelli
K. B. N. Rao
B. Manikandan
S. Visser
A. C. T. Cobos
V. Parmar
Y. Kayola
S. K. Natarajan

30 more authors

Y. Patel
J. Zhang
H. Shah
S. D. Vallabhapurapu
S. R. Khan
A. Y. Mochizuki
K. G. Abdullah
B. Hu
C.-H. G. Lucas
P. Sievers
F. Sahm
A. M. Donson
N. K. Foreman
M. F. Roussel
T. M. Pearce
P. Dirks
K. W. Pajtler
S. C. Mack
J. Rich
R. J. Gilbertson
E. C. Holland
S. K. Ramakrishnan
T. J. Abel
S. Ramachandran
S. Agnihotri
B. Zhu
S. Venneti
B. Faubert
M. D. Taylor
Hulleman

Read full text PDF DOI Cite

DNMT1-Mediated Epigenetic Reprogramming Drives KMT2A Amplifications and Rearrangements
M. A. Lineberger, Z. H. Gray, B. I. Ferman +28
bioRxiv21 Sep 2026PreprintAll rights reservedFull textOncologybioRxiv
Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer
M. Dorsch, F. E. G. Beaudry, A. K. Baginska +31
bioRxiv6 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
Targeting the USP13–ACLY axis in tumor endothelial cells: Ginsenoside Rd suppresses pathological angiogenesis through metabolic-epigenetic reprogramming
Haobin Li, Haocheng Deng, Jiali Liu +13
Acta pharmaceutica Sinica. B5 Sep 2026Peer-reviewedCC BY-NC-NDFull textPharmacology & toxicologyEurope PMCPMC
Lactate-driven metabolic-epigenetic reprogramming in breast cancer: immune evasion and therapeutic resistance.
Lei Sun, Li Wang, Wanqin Zeng +1
Clinical epigenetics1 Jul 2026Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
Metabolic-epigenetic coupling between leucine catabolism and glycolysis drives CDK4/6 inhibitor resistance
M. U. Oliphant, K. Norton, K. Kurmi +8
bioRxiv23 Sep 2026PreprintCC BY-NCFull textOncologybioRxiv

Cite

BibTeX RIS

BibTeX

@misc{yadav2026adenosylhomocysteinase,
  title = {{Adenosylhomocysteinase drives epigenetic and metabolic reprogramming in ZFTA-RELA ependymoma}},
  author = {N. Yadav and O. Pelcher and R. G. R. Mooli and R. B. Cameron and A. Delaidelli and K. B. N. Rao and B. Manikandan and S. Visser and A. C. T. Cobos and V. Parmar and Y. Kayola and S. K. Natarajan and Y. Patel and J. Zhang and H. Shah and S. D. Vallabhapurapu and S. R. Khan and A. Y. Mochizuki and K. G. Abdullah and B. Hu and C.-H. G. Lucas and P. Sievers and F. Sahm and A. M. Donson and N. K. Foreman and M. F. Roussel and T. M. Pearce and P. Dirks and K. W. Pajtler and S. C. Mack and J. Rich and R. J. Gilbertson and E. C. Holland and S. K. Ramakrishnan and T. J. Abel and S. Ramachandran and S. Agnihotri and B. Zhu and S. Venneti and B. Faubert and M. D. Taylor and Hulleman},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.06.757085},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.06.757085v1},
}

RIS

TY  - UNPB
TI  - Adenosylhomocysteinase drives epigenetic and metabolic reprogramming in ZFTA-RELA ependymoma
AU  - N. Yadav
AU  - O. Pelcher
AU  - R. G. R. Mooli
AU  - R. B. Cameron
AU  - A. Delaidelli
AU  - K. B. N. Rao
AU  - B. Manikandan
AU  - S. Visser
AU  - A. C. T. Cobos
AU  - V. Parmar
AU  - Y. Kayola
AU  - S. K. Natarajan
AU  - Y. Patel
AU  - J. Zhang
AU  - H. Shah
AU  - S. D. Vallabhapurapu
AU  - S. R. Khan
AU  - A. Y. Mochizuki
AU  - K. G. Abdullah
AU  - B. Hu
AU  - C.-H. G. Lucas
AU  - P. Sievers
AU  - F. Sahm
AU  - A. M. Donson
AU  - N. K. Foreman
AU  - M. F. Roussel
AU  - T. M. Pearce
AU  - P. Dirks
AU  - K. W. Pajtler
AU  - S. C. Mack
AU  - J. Rich
AU  - R. J. Gilbertson
AU  - E. C. Holland
AU  - S. K. Ramakrishnan
AU  - T. J. Abel
AU  - S. Ramachandran
AU  - S. Agnihotri
AU  - B. Zhu
AU  - S. Venneti
AU  - B. Faubert
AU  - M. D. Taylor
AU  - Hulleman
PY  - 2026
DA  - 2026/10/06
PB  - bioRxiv
DO  - 10.64898/2026.10.06.757085
UR  - https://www.biorxiv.org/content/10.64898/2026.10.06.757085v1
ER  -

Related

Cite